http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10167976-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b065102cea3bac2ebedde93bf4a79007 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate | 1997-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed6ff6208dd4aa5d96105a4f8294b2d0 |
publicationDate | 1998-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H10167976-A |
titleOfInvention | Immune activator and regenerating activator for normalizing damaged tissues |
abstract | (57) [Summary] [Problem] In old age, the ability of immunity to eliminate pathogens such as bacteria and viruses rapidly declines, and the ability of non-self-recognition of immune cells to decline causes self organs to weaken and cause pathogens. The reserve capacity to withstand intrusion is reduced. Also, reverse eyelashes, Aging phenomena such as hair growth at the entrance of the ear canal and occurrence of arrhythmia also occur. These phenomena are solved by an immunity enhancer having no side effects and an immunity enhancer for preventing aging. Another object of the present invention is to increase the activity of cells at the damaged site in the human body, and to increase the range of types of normalizable and reproducible sites and their recovery levels. SOLUTION: The decrease in immunity and the aging phenomenon, that is, the decrease and mutation of cell function, are combined with the action of trace amounts of various hormones originally possessed by human beings with extremely high activity, thereby increasing the amount of endogenous prostaglandin. By taking an immunopotentiator consisting of cisapride, cisapride and yoquinin, normalization occurs without any side effects in the natural metabolic mechanism. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000086451-A |
priorityDate | 1996-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.